Multiple Choice
A patient will be taking dabigatran (Pradaxa) as part of treatment for chronic atrial fibrillation. Which statements about dabigatran are true?
A) The dose of dabigatran is reduced in patients with decreased renal function.
B) Bleeding is the most common adverse effect.
C) Idarucizumab (Praxbind) is given as an antidote in cases of uncontrolled bleeding.
D) Dabigatran levels are monitored by measuring prothrombin time/international normalized ratio (PT/INR) results.
E) This drug is a prodrug and becomes activated in the liver.
Correct Answer:
Verified
Correct Answer:
Verified
Q5: A patient has received an overdose of
Q6: The nurse notes in the patient's medication
Q7: A patient is being discharged on anticoagulant
Q8: An elderly patient has had hip surgery
Q9: A patient has received an overdose of
Q10: The nurse is reviewing new medication orders
Q11: A patient who has been anticoagulated with
Q13: A patient is receiving thrombolytic therapy, and
Q14: A patient is receiving heparin therapy as
Q15: When administering heparin subcutaneously, the nurse will